首頁 > 市場調查報告書 > 醫療設備

生物材料

神經修復與再生市場規模、佔有率及成長分析（按產品、流程及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1897858

神經修復與再生市場規模、佔有率及成長分析（按產品、流程及地區分類）－2026-2033年產業預測

Nerve Repair and Regeneration Market Size, Share, and Growth Analysis, By Product (Biomaterials, Neurostimulation and Neuromodulation Devices), By Surgery (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球神經修復和再生市場規模預計在 2024 年達到 95.5 億美元，從 2025 年的 107.2 億美元成長到 2033 年的 271.3 億美元，在預測期（2026-2033 年）內複合年成長率為 12.3%。

由於神經系統疾病的日益普遍，全球神經修復和再生市場正經歷顯著成長。包括帕金森氏症和阿茲海默症在內的神經退化性疾病的增加，推動了對以神經細胞再生和修復為重點的先進治療方法的需求。外科技術、生物製藥和醫療設備的創新顯著改善了神經系統疾病的治療效果，進一步推動了市場發展。儘管醫療領域的動盪影響了慢性病管理，但中樞神經系統治療（例如神經移植、幹細胞療法和神經保護劑）的持續進步，使該領域的未來充滿希望。神經修復的應用範圍從退化性疾病擴展到創傷性損傷，這代表著一個充滿活力的市場，在研發和創新的推動下，該市場有望持續成長。

全球神經修復與再生市場促進因素

全球神經修復和再生市場主要受多發性硬化症、帕金森氏症、阿茲海默症和脊髓損傷等神經系統疾病發病率上升的驅動。隨著人口老化和生活方式相關因素加劇這些疾病的發生，對有效治療方法的需求持續成長。在醫療體系發達的地區，這趨勢特別顯著，創新型神經修復療法在這些地區正日益普及。人們對神經系統疾病有效管理的認知不斷提高，以及對有效管理的需求不斷成長，正在推動市場擴張，並反映出人們致力於改善神經系統疾病患者預後的廣泛努力。

全球神經修復與再生市場阻礙因素

全球神經修復和再生市場面臨的主要挑戰之一是現代神經修復療法（包括幹細胞療法和再生醫學）的高成本。這些先進治療方法通常需要在技術和研發方面投入大量資金，使得相當一部分患者，尤其是在中低收入國家，難以負擔。此外，高昂的治療費用阻礙了這些療法的廣泛應用，並成為醫療預算有限地區市場成長的障礙。因此，資金仍是限制這些創新醫療解決方案普及和應用的重要阻礙因素。

全球神經修復與再生市場趨勢

在提升病患體驗需求的驅動下，微創技術的應用已成為全球神經修復與再生市場的一大趨勢。腹腔鏡、內視鏡和機器人輔助手術等微創手術因其疼痛減輕、恢復更快、併發症率更低等優勢而日益受到青睞。這種轉變不僅改善了治療效果，也簡化了操作流程，為醫療保健行業的更廣泛接受和應用鋪平了道路。隨著這些技術的不斷發展，預計將顯著推動市場成長，並重塑神經損傷的治療模式。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
其他歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
亞太其他地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Medtronic（US）
Boston Scientific Corporation（US）
Abbott Laboratories（US）
Stryker Corporation（US）
AxoGen, Inc.（US）
Integra LifeSciences Holdings Corporation（US）
Baxter International Inc.（US）
Nevro Corp（US）
LivaNova PLC（UK）
Cyberonics Inc.（US）
Orthofix Medical Inc.（US）
Polyganics（Netherlands）
Nuvectra Corporation（US）
Polyganics BV（Netherlands）
BioTime Inc.（US）
Collagen Matrix, Inc.（US）
Synovis Micro Companies Alliance, Inc.（US）
StimGuard LLC（US）
Nexeon MedSystems Inc.（US）
Checkpoint Surgical, Inc.（US）

簡介目錄

Product Code: SQMIG35I2162

Global Nerve Repair and Regeneration Market size was valued at USD 9.55 Billion in 2024 and is poised to grow from USD 10.72 Billion in 2025 to USD 27.13 Billion by 2033, growing at a CAGR of 12.3% during the forecast period (2026-2033).

The global nerve repair and regeneration market is experiencing significant growth driven by the rising prevalence of neurological disorders. Conditions such as Parkinson's, Alzheimer's, and other neurodegenerative diseases have heightened the demand for advanced therapies focused on neuron regeneration and repair. Innovations in surgical methodologies, biologics, and medical devices have markedly enhanced treatment outcomes for neurological conditions, further propelling market advancement. Although healthcare disruptions impacted chronic disease management, the future of this sector looks promising with ongoing advancements in central nervous system therapies, including nerve grafts, stem cell interventions, and neuroprotective agents. The expansion of applications for nerve repair, from degenerative diseases to traumatic injuries, is indicative of a robust market poised for continued growth fueled by research and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nerve Repair and Regeneration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nerve Repair and Regeneration Market Segments Analysis

Global Nerve Repair and Regeneration Market is segmented by Product, Surgery and region. Based on Product, the market is segmented into Biomaterials and Neurostimulation and Neuromodulation Devices. Based on Surgery, the market is segmented into Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and Neurostimulation and Neuromodulation Surgeries. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nerve Repair and Regeneration Market

The Global Nerve Repair and Regeneration market is significantly fueled by the rising incidence of neurological disorders such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and spinal cord injuries. As populations age and lifestyle-related factors contribute to an increase in these conditions, the demand for effective treatment options continues to escalate. This trend is particularly notable in regions with advanced healthcare systems, where innovative nerve repair therapies are gaining traction. The growing awareness and need for effective management of neurological issues drive the expansion of the market, reflecting a broader commitment to enhancing patient outcomes in nerve health.

Restraints in the Global Nerve Repair and Regeneration Market

A major challenge facing the Global Nerve Repair and Regeneration market is the high cost associated with contemporary nerve repair therapies, including stem cell treatments and regenerative medicine. These advanced therapies often require substantial financial investment in both technology and research, rendering them inaccessible for a significant portion of the patient population, particularly in low- and middle-income countries. Additionally, the elevated treatment expenses can inhibit widespread adoption, posing a barrier to market growth in regions with limited healthcare budgets. Consequently, the financial aspect remains a significant restraint, limiting the potential reach and implementation of these innovative medical solutions.

Market Trends of the Global Nerve Repair and Regeneration Market

The Global Nerve Repair and Regeneration market is witnessing a significant trend towards the adoption of less invasive techniques, driven by the demand for improved patient experiences. Minimally invasive procedures, including laparoscopic surgery, endoscopy, and robotic-assisted operations, are gaining traction due to their benefits of reduced pain, shorter recovery times, and lower complication rates. This shift not only enhances therapeutic outcomes but also streamlines operational processes, paving the way for broader acceptance and implementation across the healthcare sector. As these technologies continue to evolve, they are expected to significantly enhance market growth and reshape treatment paradigms for nerve injuries.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Macroeconomic Indicators
Top Investment Analysis

Global Nerve Repair and Regeneration Market by Product Type

Market Overview
Neurostimulation and Neuromodulation Devices
Biomaterials

Global Nerve Repair and Regeneration Market by Application

Market Overview
Peripheral Nerve Injury
Epilepsy
Parkinson's Disease
Alzheimer's Disease

Global Nerve Repair and Regeneration Market Size by Region

Market Overview
North America
- USA
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AxoGen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polyganics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvectra Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polyganics BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTime Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collagen Matrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synovis Micro Companies Alliance, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StimGuard LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexeon MedSystems Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Checkpoint Surgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments